Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases
Clinical trial NCT03487055 · UNKNOWN
Trial details
- NCT number
- NCT03487055
- Sponsor
- Jiangsu T-Mab Biopharma Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.